Benefits and Limitations of Psychopharmacology
Presented By:
Joseph F. Goldberg, M.D.
Clinical Professor of Psychiatry, Icahn School of Medicine at Mount Sinai
NY President-Elect, American Society of Clinical Psychopharmacology
Wednesday, June 7, 2023, 7:00PM - 9:00PM EDT
Virtual Webinar
Professional Non-Members: $40
Professional Members: $30
Student Non-Members: $20
Student Members: $10
CE’s: $25
Established professionals, early career professionals, and students from all applied, research, and academic settings are invited to attend. Tickets are non-refundable and non-exchangeable.
2 CE credits approved for NYS Psychology (PSY-0016), Social Work, Mental Health Counseling, MFT and Art Therapy
To Join the NYC-CBT Association Click Here
Workshop Description
This practical workshop will review current information about the indications for pharmacotherapy in major mood, psychotic and anxiety disorders, and explore the strengths and limitations of currently available psychotropic medications. Predictors of placebo responsivity, as well as clinical (e.g., symptom cluster) and biological (e.g., pharmacogenetic) predictors of drug responsivity will also be reviewed. Decision-making regarding pharmacotherapy versus psychotherapy versus their combination in major depression will be discussed, as will the role of patient preference on treatment outcome. Finally, strategies for managing ultra-treatment resistant mood disorders in the setting of pharmacological futility will be explored.
Agenda
7:00 - 7:10 PM - Introductions
7:10 - 8:30 PM - Presentation
8:30 - 9:00 PM - Questions and discussion
Learning Objectives
Recognize clinical factors associated with response to pharmacotherapy versus psychotherapy versus their combination in mood disorders
Describe the relative effect sizes of current medications used to treat major mood, anxiety and psychotic disorders
Recognize predictors of placebo responsivity and of drug responsivity in clinical trials of mood, anxiety and psychotic disorders
Speaker Biography
Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois-Chicago, and medical school at Northwestern University Medical School, then completed his psychiatry training and psychopharmacology research fellowship at the Payne Whitney Clinic of New York Presbyterian Hospital. His research has focused on the clinical phenomenology, treatment and outcome of mood disorders. He has published over 230 peer-reviewed papers on psychopharmacology and mood disorders, as well as four books, most recently "Practical Psychopharmacology: Translating Findings From Evidence-Based Trials into Real-World Clinical Practice” published in 2021 by Cambridge University Press. He is President-Elect of the American Society of Clinical Psychopharmacology and is an Editor for the Journal of Clinical Psychiatry. Dr. Goldberg is a Distinguished Life Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly's "America's Top Doctors.”